Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Becton Dickinson and Co (BDX) vs NetEase Inc (NTES) Price & Performance

Becton Dickinson and CoTrade
NetEase IncTrade

Price performance (Past 24H)

Key statistics

Becton Dickinson and Co vs NetEase Inc — how do they compare? Becton Dickinson and Co trades at $178.95 (market cap $49.41B), while NetEase Inc trades at $123.58 (market cap $82.75B). The key difference: NetEase Inc is the larger of the two by market cap, and NetEase Inc pays the higher dividend (2.36%). Which is the better fit depends on your goals.

BDXNTES
Market Cap
$49.41B$82.75B
Sector
HealthMedia
52-Week High
$185.39$159.34
52-Week Low
$138.62$109.26
Enterprise Value
$65.51B$59.05B
Dividend Yield
2.32%2.36%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Becton Dickinson and Co

BDX trades at $179.63, up 1.57% with a bullish technical outlook supported by moving averages. The company reported strong Q3 2026 earnings, beating estimates with $3.23 EPS versus $3.14 expected, and raised full-year guidance. Revenue growth remains steady at 4.4% FX-neutral, though margins face pressure from tariffs. Analysts maintain a mixed consensus with 47% buy ratings and a $183 price target, suggesting modest upside from current levels.

The stock presents a balanced opportunity with solid fundamentals and dividend stability, but faces headwinds from margin compression and competitive pressures. Near-term catalysts include continued execution on growth initiatives, while risks include tariff impacts and healthcare regulatory changes. The current valuation at 31.39 P/E appears fair given growth prospects.

NetEase Inc

NetEase (NTES) trades at $133.41, up 0.9% with bullish technical signals and strong fundamentals. The stock shows robust profitability with 29.84% net margins and 22.12% ROE, supported by consistent revenue growth to $112.63B in 2025. Recent Q1 2026 earnings beat expectations at $2.53 EPS versus $2.19 forecast. Technical analysis indicates bullish momentum with support at $131 and resistance at $135, while analyst consensus remains strongly positive with 82% buy ratings.

Outlook remains favorable given strong cash flow generation ($50.74B operating cash flow) and international expansion potential. Key risks include Chinese regulatory environment and competitive pressures. With attractive valuation at 16.31 P/E and bullish institutional sentiment, NTES presents growth opportunity though investors should monitor earnings consistency and market volatility.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Becton Dickinson and Co

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.

Read more on BDX

About NetEase Inc

NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).

Read more on NTES